Trials / Recruiting
RecruitingNCT02848274
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2016-07-28
- Last updated
- 2025-10-22
Locations
13 sites across 7 countries: United States, Argentina, Australia, Brazil, China, Japan, United Kingdom
Source: ClinicalTrials.gov record NCT02848274. Inclusion in this directory is not an endorsement.